Suansing, Hyacinth Mae .
HRN: 11-10-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CEFUROXIME 750MG (VIAL)
05/18/2026
05/25/2026
IV
750MG
Q8
T/c UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: